Mycobacterial mutants affecting host apoptosis

Details for Australian Patent Application No. 2006204907 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Jacobs, William R.; Porcelli, Steven A.; Braunstein, Miriam; Briken, Volker

Agent Shelston IP

Pub. Number AU-B-2006204907

PCT Pub. Number WO2006/076519

Priority 60/643,614 12.01.05 US

Filing date 12 January 2006

Wipo publication date 20 July 2006

Acceptance publication date 11 August 2011

International Classifications

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 49/00 (2006.01) Preparations for testing

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076519 Priority application(s): WO2006/076519

11 August 2011 Application Accepted

  Published as AU-B-2006204907

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204911-Modified beta thymosin peptides

2006204896-Method for producing a vaccine for the treatment of cancer